You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ABCL Exercise Disclosure
Booth Andrew · SEC Form 4 · Filed Jun 3, 2026
Exercise
Calculated transaction value
$0
Booth Andrew Chief Financial Officer
ABCL
Transaction date
Jun 3, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed same day
ABCL daily price context
Close on/before transaction
$5.72
Jun 3, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Share option (right to buy) on Common Shares
- Quantity / price
- 250,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001834411-26-000006
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$47.5K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Abcellera Biologics Inc. ABCL | Exercise | Jun 3, 2026 | $47.5K |
| Abcellera Biologics Inc. ABCL Current | Exercise | Jun 3, 2026 | $0 |